Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
Where appetite circuitry is examined, immediate-early gene markers and neuropeptide expression in hypothalamic nuclei can complement behavioral readouts
Latisha Vita PLynxera GLP-1 Liquid Drops Review FAQs Q: Does Vita PLynxera GLP-1 Liquid Drops really help with weight loss
Retatrutide is projected to receive FDA approval in late 2027 or 2028
No phone or Wi-Fi setup
Excess body fat, particularly visceral fat surrounding your organs, acts as an active endocrine organ
